Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lixisenatide versus insulin glulisine for renal physiology in type 2 diabetes
2014-002178-35Phase 4Completed
- Sponsor
- VU University Medical Center
- Start
- Aug 2014
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in type 2 diabetes mellitus (T2DM) comparing Lixisenatide plus insulin glargine with Insulin glulisine plus insulin glargine (2 arms). Primary endpoint: Change in renal hemodynamics after 8 weeks. Started Aug 2014; status: completed.
02
Drugs
lixisenatideinsulin glulisine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2014-002178-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002178-35.